Terms: = Liver cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Treatment
574 results:
1. Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
[TBL] [Abstract] [Full Text] [Related]
2. Epithelial-Mesenchymal Transformation Promotes the Progression of Hepatocellular Carcinoma through NF-κB/MMP9 Axis.
Li J; Cai Q; Wang Z; Wang L; Yang G; Zhang Z; Ge N; Hu S; Bai T
Discov Med; 2024 Apr; 36(183):666-677. PubMed ID: 38665016
[TBL] [Abstract] [Full Text] [Related]
3. [Baicalin induces ferroptosis in HepG2 cells by inhibiting ROS-mediated PI3K/Akt/FoxO3a signaling pathway].
Zhou JQ; Li HJ; Zeng YH; Chen HH; Liang WY; Zhang J; Ding FP
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1327-1334. PubMed ID: 38621980
[TBL] [Abstract] [Full Text] [Related]
4. CircSNX6 promotes proliferation, metastasis, and angiogenesis in hepatocellular carcinoma via miR-383-5p/VEGFA signaling pathway.
Tian Y; Han W; Lv K; Fu L; Zhou X
Sci Rep; 2024 Apr; 14(1):8243. PubMed ID: 38589413
[TBL] [Abstract] [Full Text] [Related]
5. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
[TBL] [Abstract] [Full Text] [Related]
6. Routine evaluation of HBV-specific T cell reactivity in chronic hepatitis B using a broad-spectrum T-cell epitope peptide library and ELISpot assay.
Wu Y; Liu X; Mao Y; Ji R; Xia L; Zhou Z; Ding Y; Li P; Zhao Y; Peng M; Qiu J; Shen C
J Transl Med; 2024 Mar; 22(1):266. PubMed ID: 38468254
[TBL] [Abstract] [Full Text] [Related]
7. Inhibition of UBA52 induces autophagy via EMC6 to suppress hepatocellular carcinoma tumorigenesis and progression.
Tong L; Zheng X; Wang T; Gu W; Shen T; Yuan W; Wang S; Xing S; Liu X; Zhang C; Zhang C
J Cell Mol Med; 2024 Mar; 28(6):e18164. PubMed ID: 38445807
[TBL] [Abstract] [Full Text] [Related]
8. Cucurbitacin IIa promotes the immunogenic cell death‑inducing effect of doxorubicin and modulates immune microenvironment in liver cancer.
Li S; Wang S; Zhang A; Luo L; Song J; Wei G; Fang Z
Int J Oncol; 2024 Apr; 64(4):. PubMed ID: 38391053
[TBL] [Abstract] [Full Text] [Related]
9. USP14 exhibits high expression levels in hepatocellular carcinoma and plays a crucial role in promoting the growth of liver cancer cells through the HK2/AKT/P62 axis.
Zhang N; Zhang H; Yang X; Xue Q; Wang Q; Chang R; Zhu L; Chen Z; Liu X
BMC Cancer; 2024 Feb; 24(1):237. PubMed ID: 38383348
[TBL] [Abstract] [Full Text] [Related]
10. Investigation on the mechanism of the combination of eremias multiocellata and cisplatin in reducing chemoresistance of gastric cancer based on
Cheng FE; Li Z; Bai X; Jing Y; Zhang J; Shi X; Li T; Li W
Aging (Albany NY); 2024 Feb; 16(4):3386-3403. PubMed ID: 38345573
[TBL] [Abstract] [Full Text] [Related]
11. Circular RNA DNAH14 molecular mechanism in an experimental model of hepatocellular carcinoma treated with Cobalt chloride to mimic the hypoxia-like response of transcatheter arterial chemoembolization.
Liao Q; Xia W; Chen J; Wang K; Xiao E
Sci Rep; 2024 Jan; 14(1):1992. PubMed ID: 38263208
[TBL] [Abstract] [Full Text] [Related]
12. Establishment and Validation of Novel Prognostic Subtypes in Hepatocellular Carcinoma Based on Bile Acid Metabolism Gene Signatures Using Bulk and Single-Cell RNA-Seq Data.
Qu Y; Gong X; Zhao Z; Zhang Z; Zhang Q; Huang Y; Xie Q; Liu Y; Wei J; Du H
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255993
[TBL] [Abstract] [Full Text] [Related]
13. Unraveling Interaction of Rhenium-188 Microspheres with Primary Hepatic cancer Cell: A Breakthrough Study.
Aggarwal A; Kaur G; Jassal RS; Medhi B; Mittal BR; Shukla J
Cancer Biother Radiopharm; 2024 Apr; 39(3):188-195. PubMed ID: 38241504
[No Abstract] [Full Text] [Related]
14. The Prognostic and Therapeutic Roles of ARL-6 Gene in Hepatocellular Carcinoma.
Wang J; Che F; Zhao Y; Wei L; Chen D; Dai C; Zhang B; Zhou X; Yang B; Chen Z
Int J Med Sci; 2024; 21(2):207-218. PubMed ID: 38169538
[No Abstract] [Full Text] [Related]
15. Neutrophil extracellular traps promote gastric cancer cell metastasis via the NAT10-mediated N4-acetylcytidine modification of SMYD2.
Liu D; Yang X; Wang X
Cell Signal; 2024 Apr; 116():111014. PubMed ID: 38110168
[TBL] [Abstract] [Full Text] [Related]
16. Phytochemically analysed extract of Ageratina adenophora (Sprengel) R.M.King & H. Rob. initiates caspase 3-dependant apoptosis in colorectal cancer cell: A synergistic approach with chemotherapeutic drugs.
Chanu KD; Thoithoisana S; Kar A; Mukherjee PK; Radhakrishnanand P; Parmar K; Sharma N
J Ethnopharmacol; 2024 Mar; 322():117591. PubMed ID: 38104872
[TBL] [Abstract] [Full Text] [Related]
17. Inhibition of hepatocellular carcinoma growth
Li S; Cai X; Chen L; Lin M; Zhu Z; Xiao H; Nie P; Chen Q; Yang X
PeerJ; 2023; 11():e16593. PubMed ID: 38084140
[TBL] [Abstract] [Full Text] [Related]
18. Circ ubiquitin-like-containing plant homeodomain and RING finger domains protein 1 increases the stability of G9a and ubiquitin-like-containing plant homeodomain and RING finger domains protein 1 messenger RNA through recruiting eukaryotic translation initiation factor 4A3, transcriptionally inhibiting PDZ and homeobox protein domain protein 1, and promotes the metastasis of hepatocellular carcinoma.
Huang X; Zhou LZ; Feng WJ; Liu YQ; Chen M; Tang LY; Gan ZY; Zhang P
J Gastroenterol Hepatol; 2024 Mar; 39(3):596-607. PubMed ID: 38059880
[TBL] [Abstract] [Full Text] [Related]
19. Autophagy activation is required for N6-methyladenosine modification to regulate ferroptosis in hepatocellular carcinoma.
Li Y; Guo M; Qiu Y; Li M; Wu Y; Shen M; Wang Y; Zhang F; Shao J; Xu X; Zhang Z; Zheng S
Redox Biol; 2024 Feb; 69():102971. PubMed ID: 38056309
[TBL] [Abstract] [Full Text] [Related]
20. Exploring the mechanism of bioactive components of Prunella vulgaris L. in treating hepatocellular carcinoma based on network pharmacology.
Tu H; Feng Y; Wang W; Zhou H; Cai Q; Feng Y
Chem Biol Drug Des; 2024 Jan; 103(1):e14413. PubMed ID: 38040415
[TBL] [Abstract] [Full Text] [Related]
[Next]
